F5, Inc. Securities Fraud Class Action Result of Data Breach and 24% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / February 12, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class […]

OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares

OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares GlobeNewswire February 13, 2026 LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced the pricing

Modern Dental Group Celebrates 40 Years: 'Redefining Smiles. The Digital Way.'

12 February 2026, Modern Dental Group Limited ('Modern Dental' or the 'Group', stock code: 03600.HK), a leading global dental prosthetic device provider, is pleased to announce our new identity. This year, Modern Dental Group proudly marks its 40th anniversary, celebrating a rich history that began as a robust manufacturer and has evolved into a trusted

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RARE

New York, New York–(Newsfile Corp. – February 12, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025. A class action lawsuit has already been filed. If

ROSEN, LEADING INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTGN

New York, New York–(Newsfile Corp. – February 12, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, both dates inclusive (the “Class Period”), of the important March 16, 2026 lead plaintiff deadline. SO WHAT:

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / February 12, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until April 13, 2026 to file lead plaintiff applications in a securities class

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit

Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Picard Medical, Inc. (NYSE American: PMI) between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Balancer Cryptocurrency Investors to Inquire About Securities Class Action Investigation – BAL

NEW YORK, NY / ACCESS Newswire / February 12, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of investors in cryptocurrency issued by Balancer (ticker: BAL), resulting from allegations that Balancer may have issued materially misleading business information to the investing public. SO

Coupang, Inc. Notice of February 17, 2026 Application Deadline for Class Action Lawsuits – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / February 12, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Coupang, Inc. ("Coupang" or the "Company") (NYSE:CPNG) of class action securities lawsuits. CLASS DEFINITION: The lawsuit seeks to

Alkane Resources Announces Record Operating & Record Financial Results for Q2 and H1 FY2026

(AUST:ALK.AX),(TSX:ALK.TO),(OTC US:ALKEF),(Other OTC:ALKEF), PERTH, Australia, Feb. 12, 2026 (GLOBE NEWSWIRE) — Alkane Resources Limited (“Alkane” or the “Company”) (ASX: ALK, OTC: ALKRY, TSX: ALK) is pleased to announce financial results for the six months ended 31 December 2025 (the “half” or “HY 2026”). The Company's condensed and consolidated interim financial result for the half, together

Scroll to Top